Protection from ionizing irradiation or chemotherapeutic drug damage by in vivo gene therapy

   
   

A method of protecting a subject against an agent that elicits production of toxic free radicals, superoxide anions, or heavy metal cations in the subject is disclosed which entails in vivo administration to the subject of a polynucleotide encoding a protein that is transiently expressed in said subject. The transiently expressed protein is capable of neutralizing or eliminating the toxic free radicals, superoxide anions or heavy metal cations that are elicited by the agent. The method is particularly useful in protecting cancer patients against the damaging effects of ionizing radiation and chemotherapeutic drugs. A composition useful in carrying out the method also is disclosed.

 
Web www.patentalert.com

< Modulating a pharmacokinetic property of a drug by administering a bifunctional molecule containing the drug

< Forms of 5-azacytidine

> Microparticle protection of therapeutic agents

> Secretory membrane protein that induces osteoblast differentiation

~ 00177